Mutlu Doğan
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
-
- Venous Thromboembolism Diagnosis and Management
Papers in
- Oncology 35
- Inflammatory Biomarkers in Disease Prognosis 9
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 4
-
- Lung Cancer Treatments and Mutations 5
- Advanced Breast Cancer Therapies 4
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Nurullah Zengin (20 shared papers)Fahriye Tuğba Köş (6 shared papers)Nuriye Özdemir (9 shared papers)Doğan Uncu (13 shared papers)Gökmen Umut Erdem (8 shared papers)Esra Karakaş (3 shared papers)Ahmet DEMİRKAZIK (7 shared papers)Öznur Bal (13 shared papers)
- Journals
- Medical Oncology (4 papers)Annals of Surgical Oncology (3 papers)Annals of Oncology (3 papers)Leukemia Research (2 papers)Cancer Investigation (2 papers)
- Partner nations
- TürkiyeUnited StatesBahrain
In The Last Decade
Mutlu Doğan
85 papers receiving 635 citations
Peers
Comparison fields: 5 of 63
- Oncology 234
- Internal Medicine 19
- Cancer Research 71
- Pulmonary and Respiratory Medicine 115
- Hematology 28
Countries citing papers authored by Mutlu Doğan
This map shows the geographic impact of Mutlu Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutlu Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutlu Doğan more than expected).
Fields of papers citing papers by Mutlu Doğan
This network shows the impact of papers produced by Mutlu Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutlu Doğan. The network helps show where Mutlu Doğan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mutlu Doğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 47 | |
| 2 | 2021 | 44 | |
| 3 | 2015 | 30 | |
| 4 | 2016 | 30 | |
| 5 | Endpoints in oncology clinical trials. | 2018 | 30 |
| 6 | 2021 | 28 | |
| 7 | 2017 | 26 | |
| 8 | 2016 | 23 | |
| 9 | 2016 | 20 | |
| 10 | 2015 | 18 | |
| 11 | 2023 | 18 | |
| 12 | 2005 | 16 | |
| 13 | 2017 | 16 | |
| 14 | 2005 | 13 | |
| 15 | 2006 | 12 | |
| 16 | 2020 | 12 | |
| 17 | 2010 | 10 | |
| 18 | Two cases with atypical metastasis in colorectal cancer: splenic and renal metastasis. | 2010 | 9 |
| 19 | 2011 | 9 | |
| 20 | 2012 | 9 |
About Mutlu Doğan
Mutlu Doğan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Dermatology, having authored 94 papers that have together received 651 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Oncology (234 citations), Internal Medicine (19 citations), Cancer Research (71 citations), Pulmonary and Respiratory Medicine (115 citations) and Hematology (28 citations). Mutlu Doğan has collaborated with scholars based in Türkiye, United States and Bahrain. Frequent co-authors include Nurullah Zengin, Fahriye Tuğba Köş, Nuriye Özdemir, Doğan Uncu, Gökmen Umut Erdem, Esra Karakaş, Ahmet DEMİRKAZIK, Öznur Bal, Nebi Serkan Demirci and Fikri İçlı. Their work appears in journals such as Medical Oncology, Annals of Surgical Oncology, Annals of Oncology, Leukemia Research and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.